Member Info for Ghia

Scinv - Probably best to brush up on accounting standards.

TP - I would concur the board are genuine honest people. For some this is their life’s work and the only criticism is they may be overly detailed orientated and lack some business savy.

The real issue here is PI’s who joined the bandwagon gambling money they can’t afford to loose and now expecting regular updates.

When investors realise how insignificant they are in the big picture they might learn to sit tight and wait or move on.

Mani - You could argue they did everything they promised to do in the last raise in delivering a P3 which unfortunately narrowly missed the mark.

Until they ask for more funds I don’t see an issue with what they are doing.

And believe me if they are gearing up to ask for more funds they’d be very vocal with the market.

Observations that you may have missed.

When SNG did their first website update post P2 Prior to kick off of P3 they had a prominent advert for recruiting new research.

Soon after in Nov 2020 Pedro moved internally into a new role as Clinical Research Nurse Manager.

Off the back of this UNiVERSAL came about.

This has been about furthering research and utilising the staff they have which would no longer be contributing to the covid objective as the trials became bigger, global and US centric.

Dunk - Do your own research, it’s all out there in the public domain if you know how to look and who to ask. Two of the names are in the mine and others chat history recently and historically.

Dunk - Well I know the names of 3 of the part time nurses that are definitely deployed on it.

Fruits - Personally I think it's at least a team of 6+ probably resources that are part time SNG and part time sotton. Pedro who manages the team is SNG full time and transitioned into the role for Universal.

Unless TW pulled a favour to reduce SNG’s overheads which are under pressure.

New ISA allowance soon this will be worth a punt on speculation.

No Mani Nov 2020 this is when Pedro moved onto the project.

UNIVERSAL has roots that stretch back as far as Nov 2020 that’s when SNG started to deploy resource to it.

No Dunk there was no intention I just said that a lot of staff had been diverted. What are you even suggesting I was inferring from that?

If you want to be pedantic I have no idea how many but I assume it’s more than one and less than 10. But for a company the size of SNG 2 staff could be seen as a lot, it’s all relative.

The good news is these nursing staff got diverted onto another project and didn’t have to find work elsewhere due to the current lull. Skills retained not lost.

I think people need to chill out the witch hunting is insane!

Dunk - read the flipping announcement!!

“Viral testing equipment already owned by Synairgen and nursing staff at the Southampton clinical trial site are being provided by Synairgen”

This drop into the 8’s fuelled by people realising losses into the new tax year?

It’s why I went early.

Bob - A lot of the clinical staff got diverted to the Universal trial which will have avoided job losses.

Doc83 - Yet it’s the winter remark that has been the backbone of the fierce defence on this board.

SSH’s comment ref no commercialisation within 12months was a much more sincere comment and should have set the expectations of the investor accordingly.

It’s no surprise though the positive spin is always more palatable when you are invested in the outcome.

They built two new facilities in quick succession and have acquired businesses that likely came with floor space.

Their latest acquisition in the U.K. is geographically located in Norfolk which is likely a cheaper location to operate than their HQ in Bradford On Avon.

It’s possible some of these factors are behind the decision IMO.

Tommy - &?

Ultimately Pfizer have managed to sell their drug because they know how to navigate the process.

Every time I’m in the states the number of TV adverts I see for PAX is impressive have to hand it to them they know what they are doing.

Mani - “ IMHO RM's behaviour is questionable.”

If you had attended the AGM you would have witnessed the line of questioning around the chairman’s position.

IMO The chairman must go at the next AGM as the length of service of both the chairman and CEO is not in the interest of the shareholders.

As for RM jury is out his next move needs to be progressive.

Mani - I never said I’m always right.

Clearly said I had a theory that theory didn’t pan out.

But importantly I had an investment strategy which is now into its next phase.

Rather than sit and wait for the best I prefer to draw up plans and then let them run their course.

Clearly you don’t and got in a flap when you realised things didn’t align with your assumptions.

There are others here who are happy to bust or flush which again is a perfectly legitimate strategy. At least they have one!

Best get your strategy sorted.